Original language | English |
---|---|
Pages (from-to) | e270-e273 |
Journal | Haematologica |
Volume | 103 |
Issue number | 6 |
DOIs |
|
State | Published - Jun 3 2018 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Haematologica, Vol. 103, No. 6, 03.06.2018, p. e270-e273.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a t-cell infiltrate in the bone marrow
AU - Bansal, Dhruv
AU - Vij, Kiran
AU - Chang, Gue Su
AU - Miller, Christopher A.
AU - Dipersio, John F.
AU - Vij, Ravi
AU - Heath, Sharon E.
AU - Westervelt, Peter
AU - Welch, John S.
AU - Fehniger, Todd A.
N1 - Funding Information: Funding: support was also provided by NCI Leukemia SPORE (P50 CA171963) and the Genomics of AML Program Project grant (P01 CA101937). TAF is supported by R01CA205239. We thank Greg Malnassy, Nichole Helton, and the Washington University Tissue Procurement Core for sample storage and sample preparation. We thank Timothy Schappe for assistance with sample collection. We thank all BMT/Leukemia treatment teams and all patients who elected to participate in this clinical trial. Correspondence: [email protected]/[email protected] doi:10.3324/haematol.2017.184168 Information on authorship, contributions, and financial & other disclosures was provided by the authors and is available with the online version of this article at www.haematologica.org.
PY - 2018/6/3
Y1 - 2018/6/3
UR - http://www.scopus.com/inward/record.url?scp=85048055103&partnerID=8YFLogxK
U2 - 10.3324/haematol.2017.184168
DO - 10.3324/haematol.2017.184168
M3 - Comment/debate
C2 - 29567774
AN - SCOPUS:85048055103
SN - 0390-6078
VL - 103
SP - e270-e273
JO - Haematologica
JF - Haematologica
IS - 6
ER -